Insights

Strategic partnerships Nanotein’s recent collaboration with Sartorius Stedim Biotech to co-develop products via the NanoSpark platform signals strong partnership value and a potential path for joint offerings. Target accounts in cell and gene therapy seeking scalable platforms should be engaged for co-development or co-marketing opportunities.

Growth potential With a focused product line on accelerating CAR-T and NK cell expansion and shifting growth profiles toward clinically durable sub-populations, Nanotein addresses high-value bottlenecks in CAR-T manufacturing, presenting opportunities to upsell platform access, licenses, or contract research services to biotech and pharma companies expanding gene therapy pipelines.

Market momentum Publicized activity around NK activation reagent launches and participation in major cell and gene therapy events indicate active market entry and brand visibility. Leverage conference and press momentum to position Nanotein for pilot programs, demonstrations, and early-adopter partnerships with biotech firms investing in COG-T and NK platforms.

Financial footing Current revenue range and modest funding level suggest openness to strategic investments or collaborations that unlock faster product development and go-to-market timelines. Explore grant, non-dilutive funding, or co-development funding discussions with potential customers or investors to accelerate commercialization.

Tech-enabled sales A tech stack oriented toward marketing automation and digital engagement (HubSpot, Google Workspace, CMS tools) coupled with a lean team implies a scalable, outbound-led sales model. Propose targeted outbound campaigns to biotech startups and mid-size biopharma companies pursuing CAR-T/NK therapies, backed by digital-led case studies and pilot-ready proposals.

Similar companies to Nanotein Technologies, Inc.

Nanotein Technologies, Inc. Tech Stack

Nanotein Technologies, Inc. uses 8 technology products and services including Microsoft Advertising, HubSpot Analytics, Linkedin Insight Tag, and more. Explore Nanotein Technologies, Inc.'s tech stack below.

Media & News

Nanotein Technologies, Inc.'s Email Address Formats

Nanotein Technologies, Inc. uses at least 1 email format:
Nanotein Technologies, Inc. Email FormatsExamplePercentage
First@nanoteintech.comJohn@nanoteintech.com
100%

Frequently Asked Questions

What is Nanotein Technologies, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Nanotein Technologies, Inc.'s official website is nanoteintech.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nanotein Technologies, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Nanotein Technologies, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Nanotein Technologies, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Nanotein Technologies, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nanotein Technologies, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Nanotein Technologies, Inc. has approximately 6 employees across 2 continents, including North America and Europe. Key team members include Member Board Of Directors: D. D. Explore Nanotein Technologies, Inc.'s employee directory with LeadIQ.

What industry does Nanotein Technologies, Inc. belong to?

Minus sign iconPlus sign icon
Nanotein Technologies, Inc. operates in the Biotechnology Research industry.

What technology does Nanotein Technologies, Inc. use?

Minus sign iconPlus sign icon
Nanotein Technologies, Inc.'s tech stack includes Microsoft Advertising, HubSpot Analytics, Linkedin Insight Tag, Wix, WordPress, WooCommerce, Google Workspace and WP Engine.

What is Nanotein Technologies, Inc.'s email format?

Minus sign iconPlus sign icon
Nanotein Technologies, Inc.'s email format typically follows the pattern of First@nanoteintech.com. Find more Nanotein Technologies, Inc. email formats with LeadIQ.

How much funding has Nanotein Technologies, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Nanotein Technologies, Inc. has raised $3M in funding. The last funding round occurred on Aug 11, 2025 for $3M.

When was Nanotein Technologies, Inc. founded?

Minus sign iconPlus sign icon
Nanotein Technologies, Inc. was founded in 2019.
Nanotein Technologies, Inc. logo

Nanotein Technologies, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Nanotein Technologies, Inc. is a small biotechnology company based in Berkeley, California, focused on cell therapy research. Its platform addresses key challenges in the CAR-T field by accelerating expansion, increasing cell yield per treatment, and shifting growth toward longer-lived, clinically effective CAR-T sub-populations. The system is described as tunable and flexible, enabling modifications to cultivate CAR-T and T-cell cultures with varying population profiles and growth dynamics.

Its customers are researchers and developers in the cell and gene therapy space seeking more efficient manufacturing and product profiles for CAR-T therapies. The company engages in collaborations to expand its offerings through the NanoSpark platform, including a 2025 partnership with Sartorius Stedim Biotech to develop new product offerings for cell and gene therapy markets.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
2-10

Section iconFunding & Financials

  • $3M

    Nanotein Technologies, Inc. has raised a total of $3M of funding over 2 rounds. Their latest funding round was raised on Aug 11, 2025 in the amount of $3M as a Corporate Round.

  • $1M - $10M

    Nanotein Technologies, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.